MacroGenics | MGNX - رأس المال والاحتياطيات





رأس المال والاحتياطيات تغيير تاريخ
AbbVie USD -5.94B 721M 2026-06
Amgen USD 9.19B 532M 2026-03
AstraZeneca USD 50.3B 2.96B 2026-06
Biogen USD 18.85B 196.3M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Daiichi Sankyo JPY 1.7T 38.53B 2026-06
Eli Lilly USD 31.2B 4.66B 2026-03
Genmab DKK 5.85B 96M 2025-12
Geron USD 229.11M 3.24M 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
J&J USD 84.97B 3.78B 2026-06
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
MacroGenics USD 21.2M 34.39M 2026-03
Merck USD 45.88B 6.73B 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Xencor USD 515.63M 119.95M 2026-03